How an Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications-Reference-Cited by-同舟云学术

How an Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications

Published:2022-05 Issue:3 Volume:28 Page:227-233
ISSN:1538-1145
Container-title:Journal of Psychiatric Practice
language:en
Short-container-title:

Author:

Preskorn Sheldon H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference36 articles.

1. Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder: a randomized clinical trial;Preskorn;JAMA,2022

2. Félix Vicq d’Azyr (1746-1794): early founder of neuroanatomy and royal French physician;Tubbs;Childs Nerv Syst,2011

3. The central adrenergic system: an immunofluorescence study of the location of the cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker;Swanson;J Comp Neurol,1975

4. Anatomical evidence for central catecholaminergic innervation of the cerebral microvasculature;Hartman;J Cereb Blood Flow Metab,1981

5. Measurement of cerebral vascular extraction fractions in the rat using intracarotid injection techniques;Clark;Brain Res,1981

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative dexmedetomidine-induced delirium in a patient with schizophrenia: a case report;BMC Anesthesiology;2024-08-09

2. Administración sublingual y bucal de fármacos en situaciones de urgencia y emergencia vital;Medicina Clínica;2024-07

3. Letter to the editor: “Clonidine is associated with faster first resolution of incident ICU delirium than antipsychotics”;Journal of Critical Care;2024-02

4. Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorder;Expert Opinion on Pharmacotherapy;2023-09-04

5. Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder;Clinical Psychopharmacology and Neuroscience;2023-05-30